From the Capital of France to the Capital of New York -- a cutting-edge biotech firm that uses AI to research cancer ...

LifeSciencesNY, a trade group based in Central New York, urges state legislators to fund this effort in the upcoming state ...

Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues- Astellas to lead commercialization of VIR-5500 in the U.S. with Vir Biotechnology ...

After receiving a drug rejection from the FDA, Woburn-based Replimune Group (Nasdaq: REPL) has informed the state that it ...

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.

Data demonstrate a scalable approach to better understand tumor cell behavior and inform drug developmentDALLAS--(BUSINESS WIRE)--SingleCell Biotechnology, a biotechnology company developing ...

The incubator will be known as RoVa Labs at Carilion Clinic and will support the growth of research spinoffs and start-up ...

The first three months of 2026 saw 14 companies announce cuts. That's a ramp-up from the prior quarter, which saw 476 workers ...

Amidst rising layoffs in key biotech hubs, global demand for specialized life sciences talent is driving a more borderless, ...

Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial of ...

Eli Lilly, the maker of the popular GLP-1 injectable Mounjaro, has invested heavily in Houston as a biotechnology hub.

Dozens of Massachusetts workers are about to lose their jobs after the FDA rejected a promising cancer drug — for the second ...